JPRN-UMIN000000899
Completed
未知
Improvement effects of pioglitazone on endothelial function after sirolimus-eluting stent (Cypher stent) implantation: a randomized, open rabelled, prospective study. - Improvement effects of pioglitazone on endothelial function after Cypher stent implantation: a randomized study.
Chiba University Graduate School of Medicine0 sites50 target enrollmentNovember 19, 2007
Conditionscoronary artery disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- coronary artery disease
- Sponsor
- Chiba University Graduate School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Acute myocardial infarction, heart failure, severe hepatic or renal dysfunction, already to take pioglitazone, pregnancy and in\-stent restenotic lesion.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT01322308National Heart Institute, Mexico30
Completed
Phase 4
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.Diabetes MellitusNCT00770835Takeda39
Completed
Not Applicable
Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2DiabetesType2 diabetesJPRN-UMIN000023463Dokkyo medical university hospital30
Active, not recruiting
Phase 1
The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA - PICCOLAEUCTR2007-001222-27-GBImperial College London24
Active, not recruiting
Not Applicable
EffectS of PiogLitazone on ENDOthelial progenitoR cells in type 2 diabetic patients with vascular complications - The SPLENDOR Study - SPLENDORType 2 diabetesMedDRA version: 9.1Level: HLTClassification code 10012654Term: Diabetic complications cardiovascularEUCTR2007-003077-44-ITTAKEDA